iribrine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for iribrine, covering 2023-04-06 to 2023-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure [Phase 1, Phase 2]